New7

ADC Related

ADC Antibody ADC Cytotoxin ADC Linker ADCs Drug-Linker Conjugates for ADC
Angiogenesis

5-alpha Reductase ALK Bcr-Abl BTK EGFR FAK FLT3 HER-2 HIF Src Syk VDA VEGFR
Anti-infection

Antibiotic Arenavirus Bacterial CMV EBV Enterovirus Filovirus Fungal Gli HBV HCV HCV Protease HIV HSV Influenza Virus Parasite RABV Reverse Transcriptase RSV SARS-CoV TMV Virus Protease
Apoptosis

Apoptosis ASK Bcl-2 Caspase c-Myc c-RET Cytohesin DAPK Ferroptosis FKBP IAP Mdm2 p53 PD-1 PD-L1 PERK PKD Ras RIP kinase ROS Survivin Thymidylate Synthase TNF Receptor TNFa TRADD
Autophagy

Autophagy LRRK2 Mitophagy OGA ULK
Cell Cycle

Antifolate APC Aurora Kinase BMI-1 CDK Chk c-Myc Eukaryotic Initiation Factor G-quadruplex HDAC HSP Kinesin LIMK Mad2 Microtubule(Tubulin) Mps1 Nucleoside Antimetabolite/Analog Nur77 p21 PAK PERK PFKFB PLK PPAR Ras Rho ROCK SRPK TOPK Topoisomerase Wee1
Cytoskeletal Signaling

Arp2 3 Complex Bcr-Abl Cardiac Myosin Dynamin Gap Junction Protein HSP Integrin Kinesin Microtubule Associated MLCK Myosin PAK TACC3 Wntbeta-catenin
DNA Damage

ATM(ATR) CRISPR(Cas9) DNA alkylator DNA Stain DNA(RNA) Synthesis GAK HDAC HSP Nucleoside Antimetabolite(Analog) OGG1 p97 PARG PARP RAD51 RNR Sirtuin SMN Telomerase Topoisomerase
Endocrinology & Hormones

5-alpha Reductase ACE Adrenergic Receptor Androgen Receptor Aromatase Estrogenprogestogen Receptor Glucocorticoid Receptor GPR Mineralocorticoid Receptor RAAS THR TSH Receptor
Epigenetics

AMPK Aurora Kinase DNA Methyltransferase Epigenetic Reader Domain EZH1 2 HDAC HIF Histone Acetyltransferase Histone Demethylase Histone Methyltransferase JAK MAT MicroRNA MLL Pim PKC Protein Arginine Deiminase Sirtuin Small Interfering RNA (siRNA) SMYD

+MORE

New7

New7 related products

Cat No.	Product Name	CAS No.	Product Description
V4573	(4E)-SUN9221	222318-55-0	(4E)-SUN9221 is a potent α1-adrenergic receptor and 5-HT2 receptor blocker (antagonist) with anti-hypertensive (blood pressure lowering) and antiplatelet aggregation effects.
V4720	(±)-BI-D	1416258-16-6	(±)-BI-D is a novel and potent allosteric/noncatalytic site integrase inhibitor that binds integrase at the LEDGF/p75 binding site.
V5159	L 601920-0 (Methyl-3β-hydroxycholenate)	20231-57-6	Methyl-3β-hydroxycholenate is a ROR gamma modulator.
V4605	5Z-7-Oxozeaenol	253863-19-3	5Z-7-Oxozeaenol, a natural anti-protozoan compound isolated from fungae, is a novel, potent irreversible / covalent and selective inhibitor ofTAK1andVEGF-R2withIC50s of 8 nM and 52 nM, respectively.
V4657	A-437203	220519-06-2	A-437203 is a novel, potent and selectiveD3receptor antagonist withKiof 71, 1.6, and 6220 nM for D2, D3, and D4receptors, respectively.
V4566	ABBV-4083	1809266-03-2	ABBV-4083, a Tylosin A analog withimprovements in anti-Wolbachiaand anti-filarial activity and oral pharmacokinetic properties, is a novel macrofilaricidal agent which acts by targeting the worm-symbiont Wolbachia bacterium.
V4690	ACY-1083	1708113-43-2	ACY-1083 is a novel, potent, selective and brain-penetrant HDAC6 inhibitor with an IC50 of 3 nM.
V4689	ACY-957	1609389-52-7	ACY-957 is a novel, potent and selective inhibitor ofHDAC1andHDAC2isoforms withIC50s of 7 nM, 18 nM, and 1300 nM against HDAC1/2/3, respectively.
V4985	Ajulemic acid	137945-48-3	Ajulemic acid (also known as lenabasum) is a cannabinoid CB2 receptor agonist with the potential for treatment of skin-predominant dermatomyositis.
V4738	AMG2850	1470018-52-0	AMG2850 is a novel, potent, orally bioavailable and selectivesmall molecule antagonist oftransient receptor potential melastatin 8 (TRPM8).
V4846	AMY-101	1427001-89-5	AMY-101 (also known as Cp40) is a peptidic inhibitor of the central complement component C3.
V5051	ANT431	1639972-90-9	ANT431 is a novel and potent inhibitor of metallo-β-lactamase with the potential for the treatment of carbapenem-resistant enterobacteriaceae infections.
V4565	ARN 077	1373625-34-3	ARN 077 (ARN-077) is a novel, potent and selectiveN-acylethanolamine acid amidase (NAAA)inhibitor with anIC50of 7 nM for human NAAA.
V4991	AZD3147	1101810-02-9	AZD3147 (AZD-3147) is an highly potent and selective dual inhibitor of mTORC1/2 with IC50 of 1.5 nM.
V4982	AZD3458 (PI3Kγ inhibitor 3)	2132961-46-5	AZD-3458 (PI3Kγ inhibitor 3) is a novel, potent, orally bioavailable and highly isoform selectivePI3Kγinhibitor with anticancer activity.
V4601	Bamirastine	215529-47-8	Bamirastine (also known as TAK-427),a new imidazopyridazine derivative, is a novelantihistamine compound withantiallergic effects.
V4993	BEBT-908	1235449-52-1	BEBT-908,extracted from patent US/20120088764A1, Compound example 243, is a novel, potent and selectivePI3Kαinhibitor with anIC50<0.1 μM, it also inhibits HDAC with 0.1 μM≤IC50≤1 μM.
V4519	BGB-102	807640-87-5	JNJ-26483327 (also known as BGB102; JNJ26483327; BGB-102) is a novel, potent, reversible and orally bioavailable small-molecule multitargeted tyrosine kinase inhibitor againstEGFR,HER2, andHER4withIC50s of 9.6 nM, 18 nM and 40.3 nM, respectively.
V4702	BI-0252	1818291-27-8	BI-0252 is a novel, potent, highly selective, orally bioactiveMDM2-p53interaction inhibitor with anIC50of 4 nM.
V4714	BI-1408	2231075-94-6	BI-1408, atetrahydroindazole derivative, is a novel,centrally efficacious and potentγ secretasemodulator with anIC50of 0.04 μM forAβ42.